Dr. Veerle Dewulf
ActiveSummary
Dr. Veerle Dewulf has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €23,134 and a net result of €165,581. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 15% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Dr. Veerle Dewulf
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaamse Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Externe vertegenwoordiging Iedere bestuurder vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder, met…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Beperkt in tijd, Bestuursorgaan” (deed in Dutch)“Algemene vergadering die bestuurder(s)benoemt, onbepaalde duur bij gebrek aan bepaling” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Friday of June at 20:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Op elk moment door AV met vereisten statutenwijziging” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Alle machten artikel 2:87 WVV zonder bijzondere machtiging AV, AV kan te allen tijde bij gewone meerderheid beperken” (deed in Dutch)